There is growing evidence supporting sex differences in the incidence of AD [67,68], and, in fact, sex differences have been found in glucose metabolism in AD patients [69], supporting a potential involvement of GNPDA2 in this neurological context. The gene discussed is GNPDA2; the disease is Alzheimer disease.